EUVIMEDEUVIMED entdecken
Crossref

Novel Cocrystal Structures of Peptide Antagonists Bound to the Human Melanocortin Receptor 4 Unveil Unexplored Grounds for Structure-Based Drug Design

Luis E Gimenez iD, Charlotte Martin, Jing Yu, Charlie Hollanders, Ciria C Hernandez, Yiran Wu, Deqiang Yao, Gye Won Han, Naima S Dahir, Lijie Wu, Olivier Van der Poorten, Arthur Lamouroux und 6 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.3c01822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Luis E Gimenez und 17 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States. Hauptthemen laut MEDLINE: Receptor, Melanocortin, Type 4, Peptides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Life Sciences Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Office of the Vice President for Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanocortin 4 receptor (MC4-R) antagonists are actively sought for treating cancer cachexia. We determined the structures of complexes with PG-934 and SBL-MC-31. These peptides differ from SHU9119 by substituting His6 with Pro6 and inserting Gly10 or Arg10. The structures revealed two subpockets at the TM7-TM1-TM2 domains, separated by N2857.36. Two peptide series based on the complexed peptides led to an antagonist activity and selectivity SAR study. Most ligands retained the SHU9119 potency, but several SBL-MC-31-derived peptides significantly enhanced MC4-R selectivity over MC1-R by 60- to 132-fold. We also investigated MC4-R coupling to the K+ channel, Kir7.1. Some peptides activated the channel, whereas others induced channel closure independently of G protein coupling. In cell culture studies, channel activation correlated with increased feeding, while a peptide with Kir7.1 inhibitory activity reduced eating. These results highlight the potential for targeting the MC4-R:Kir7.1 complex for treating positive and restrictive eating disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Melanocortin, Type 4PeptidesHumansLigandsDrug DesignReceptor, Melanocortin, Type 3Receptors, Melanocortin

Substanzen

Receptor, Melanocortin, Type 4PeptidesLigandsReceptor, Melanocortin, Type 3Receptors, Melanocortin

Autor:innen und Institutionen

  • Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Research Group of Organic Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, Brussels B-1050, Belgium.
  • iHuman Institute, ShanghaiTech University, Ren Building, 393 Middle Huaxia Road, Pudong, Shanghai 201210, China.
  • Departments of Biological Sciences and Chemistry, Bridge Institute, USC Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, California 90089, United States.
  • Department of Molecular and Integrative Physiology, School of Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Department of Molecular, Cellular, and Developmental Biology, College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, Michigan 48109, United States.

ORCID-Profile: Luis E Gimenez, Morgane Mannes, Suwen Zhao, Roger D Cone, Steven Ballet

Förderung

  • Life Sciences Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Office of the Vice President for Research
  • Vrije Universiteit Brussel
  • ShanghaiTech University

Zitieren

APA

Gimenez, L. E., Martin, C., Yu, J., Hollanders, C., Hernandez, C. C., Wu, Y., Yao, D., Han, G. W., Dahir, N. S., Wu, L., Van der Poorten, O., Lamouroux, A., Mannes, M., Zhao, S., Tourwé, D., Stevens, R. C., Cone, R. D., & Ballet, S. (2024). Novel Cocrystal Structures of Peptide Antagonists Bound to the Human Melanocortin Receptor 4 Unveil Unexplored Grounds for Structure-Based Drug Design. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01822

Vancouver

Gimenez LE, Martin C, Yu J, Hollanders C, Hernandez CC, Wu Y, et al. Novel Cocrystal Structures of Peptide Antagonists Bound to the Human Melanocortin Receptor 4 Unveil Unexplored Grounds for Structure-Based Drug Design. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c01822

BibTeX
@article{Gimenez2024,
  author = {Gimenez, Luis E and Martin, Charlotte and Yu, Jing and Hollanders, Charlie and Hernandez, Ciria C and Wu, Yiran and Yao, Deqiang and Han, Gye Won and Dahir, Naima S and Wu, Lijie and Van der Poorten, Olivier and Lamouroux, Arthur and Mannes, Morgane and Zhao, Suwen and Tourwé, Dirk and Stevens, Raymond C and Cone, Roger D and Ballet, Steven},
  title = {Novel Cocrystal Structures of Peptide Antagonists Bound to the Human Melanocortin Receptor 4 Unveil Unexplored Grounds for Structure-Based Drug Design},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.3c01822}
}
Kostenlos starten →